Member Info for kingskin

:)

well looks like im wrong, bio sector has tanked but we are not following it, underwriters making their quick buck ;)

http://www.clear-uk.org/nanny-state-tabloid-lies-no-called-reformers/

yes bob, we have debated all this before, there are very lengthy threads on it, and you still think you are right, nothing will change your opinion, and you will never change mine, but you are wrong, remember we demolished your beliefs before, i suggest you refer back to it, i cant be bothered.

i'm erring on the side of the $84.77 target

they were absorbed last week, ftse is set to open down a bit,

exactly WCS, there is plenty of evidence throughout history, no more is required, which is why so many countries are moving forward, despite bobs concerns, thank god `(or whatever)

Amsterdam---40 years

re- "I don't understand what you point is with the GWP42004 trials", you seem to understand it quite well, you have simply expanded on my point.. "does that mean that cannabis cant treat diabetes?...nope just means gw got it wrong until we are proven otherwise" re- "Results on medical / herbal cannabis is always going to be more unreliable. " hmm only to a point, but if it contains the same molecules then it is reasonable to assume it will have the same effect, the body and / or the endocannabinoid system does not know one is FDA approved, at least as far as i am aware. with regard to the USA and waiting, why?, we have plenty of evidence from other countries, but lets be last, lets not be a leader, lets get left behind, lets let other countries make all the money, lets let them develop all the skills,for what? fear? belief in corrupt biased studies? some (false) sense of control? to help big pharma?

forward thinking governments, unlike our own, we could increase our GDP after brexit too... "“The production of cannabis is undoubtedly an income generating activity. Legalizing its production and consumption will contribute to the Moroccan GDP by more than 4.5 percentage points per year.”"

" In March 2014, we commenced a larger placebo-controlled Phase 2 dose ranging trial of GWP42004. The primary objective of this trial is to compare the change in glycemic control in patients with type-2 diabetes when treated with one of three doses of GWP42004 or placebo as add-on therapy, to metformin with the primary endpoint being change from baseline to the end of treatment in mean glycosylated hemoglobin A1c (HbA1c) level. The safety and tolerability of GWP42004 compared with placebo will also be assessed. This trial is now completed and a preliminary analysis of the topline data shows that this trial did not meet its primary endpoint. The drug was well tolerated with no serious adverse events. We are undertaking further evaluation of the data to determine whether to pursue further development of GWP42004 within the field of type-2 diabetes. " http://ir.gwpharm.com/secfiling.cfm?filingID=1144204-16-112989&CIK=1351288 your welcome ;)

lol, i have no probs with GW, cant speak for anyone else here bob, and neither can you, im not fond of 'big pharma' telling lies in the way that they are lobbying against medical cannabis while people die from prescribed abuse, though that has little to do with GW, its just im not callous,I work in health care, maybe you dont care about people much, i cant really say....I dont know. Im not pro medical cannabis, im pro facts and truth, thats all. pretending that cannabis is somehow different because it had fda approval is something we have been through here many times times bob, and i cant really be bothered to go all over it again, you are entitled to your belief, as im entitled to believe the facts ;) lucky for me i didnt buy at 614, so im not the least bit bitter, something felt wrong, rendrag believed the offering was due to positive diabetes data, and so did you as you agreed with him, well unlucky, you were both wrong, it is a flop....does that mean that cannabis cant treat diabetes?...nope just means gw got it wrong until we are proven otherwise.

true stevie, but how on earth can pharma even begin to justify their agenda on this? " A new study published in Health Affairs, shows that painkiller abuse and overdoses are lower in states where medical marijuana is available. The study found that in the 17 states where medical marijuana use is permitted, prescriptions for painkillers and other drug classes were significantly lower than in the states where it was not available." its laughable, if if were not so serious.

absolute disgrace! http://www.benzinga.com/general/biotech/16/07/8215665/why-big-pharma-may-push-back-against-legal-marijuana

"so far" & "time will tell" yep.....

http://presstelegraph.com/2016/07/13/after-todays-huge-decline-is-gw-pharmaceuticals-plc-adrs-near-term-analysis-negative/

cant say for sure, but the trade that caused the spike was from 5:15 the day before (it had a minus next to it) then the next trade also had a strange time on it, but was for the same amount of shares, so a bit of an anomaly, perhaps some screw up by a broker??

it was a fair enough guess, and maybe what 'they' wanted you to think, but that might just be the THC ;)

and the offering is nothing to do with the Diabetes/THCV data.... GWPH filed a prospectus detailing the offering, describing its intended use of proceeds, based on the original $150mm target: •$50.0 million to fund pre-launch commercialization activities for Epidiolex; •$30.0 million to fund further expansion of our Epidiolex manufacturing capability to meet anticipated medium and long-term demand; •$25.0 million to fund manufacture of Epidiolex inventory in preparation for launch; •$20.0 million to fund the expansion of the market opportunity for Epidiolex through clinical development of other orphan indications; •$10.0 million to fund the advancement of other pipeline opportunities; and •$6.3 million for other general corporate purposes.

have another read of the greenshoe rule to understand why we are higher than that ;)